1. Home
  2. INCR

as 06-20-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Founded: 1994 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 83.9M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 6.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.41 EPS Growth: N/A
52 Week Low/High: $1.17 - $2.62 Next Earning Date: 08-15-2025
Revenue: $65,575,323 Revenue Growth: -32.82%
Revenue Growth (this year): 69.54% Revenue Growth (next year): 41.75%

INCR Daily Stock ML Predictions

Share on Social Networks: